Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCG: the challenge continues.

P E Fine1

  • 1Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK.

Scandinavian Journal of Infectious Diseases
|May 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mixture analysis of tuberculin survey data from northern Malawi and critique of the method.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2006
Same author

Stopping a polio outbreak in the post-eradication era.

Developments in biologicals·2002
Same author

Comparison of two versus three smears in identifying culture-positive tuberculosis patients in a rural African setting with high HIV prevalence.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2001
Same author

Field-based random sampling without a sampling frame: control selection for a case-control study in rural Africa.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2001
Same author

The development of the HIV epidemic in Karonga District, Malawi.

AIDS (London, England)·2001
Same author

Environmental mycobacteria in northern Malawi: implications for the epidemiology of tuberculosis and leprosy.

Epidemiology and infection·2001
Same journal

Fas-Ligand Mediated Apoptosis in Severe Sepsis and Shock.

Scandinavian journal of infectious diseases·2017
Same journal

Lipopolysaccharide-inducible Gene Expression Profile in Human Monocytes.

Scandinavian journal of infectious diseases·2017
Same journal

Fatal varicella pneumonia.

Scandinavian journal of infectious diseases·2015
Same journal

Wissler's Syndrome Associated with Parainfluenza 2 Infection.

Scandinavian journal of infectious diseases·2015
Same journal

Contamination of smears with "sergentella spiroides".

Scandinavian journal of infectious diseases·2015
Same journal

Recrudescent typhus: fluctuations in titers of complement-fixing and microagglutinating antibodies to rickettsia prowazeki in persons with a history of epidemic typhus.

Scandinavian journal of infectious diseases·2015
See all related articles

The Bacillus Calmette-Guérin (BCG) vaccine offers inconsistent protection against tuberculosis (TB), particularly waning after 15 years and showing reduced efficacy in older individuals. This challenges its effectiveness for adult TB prevention.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases
  • Public Health

Background:

  • The Bacillus Calmette-Guérin (BCG) vaccine is the primary vaccine used globally against tuberculosis (TB).
  • BCG's efficacy is known to be variable and often insufficient, with protection declining in older populations.
  • Existing efficacy estimates do not fully capture the complexities of BCG protection across different age groups and populations.

Purpose of the Study:

  • To analyze the age- and time-dependent effects on BCG vaccine protection against tuberculosis.
  • To investigate the implications of waning BCG immunity for the development of new adult TB vaccines.

Main Methods:

  • Review of existing studies on BCG efficacy, focusing on age-related protection trends.

Related Experiment Videos

  • Analysis of recent epidemiological data from South India examining BCG's impact on different age cohorts over time.
  • Consideration of factors influencing BCG effectiveness, such as prior mycobacterial exposure and disease type (primary vs. reactivation/reinfection).

    • Main Results:

    • BCG vaccination demonstrated consistent protection in children.
    • Protection from BCG was absent in individuals over 15 years old.
    • Evidence suggests potential negative protection (increased susceptibility) in individuals over 15 years old.

    Conclusions:

    • BCG's protective effect is not lifelong and diminishes significantly after 15 years.
    • Age-specific waning immunity and potential negative protection in older adults necessitate new vaccine development strategies.
    • Findings have critical implications for developing effective tuberculosis vaccines targeting adult pulmonary disease.